glp-1 heart attack medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 drugs may cut risk

Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions

Compounded semaglutide is widely used for chronic weight management in adults who are overweight or obese, even without diabetes, as long as they meet the clinical criteria and have no contraindications

Effect of grape pomace polyphenols with or without pectin on TMAO serum levels assessed by LC/MS-based assay: a preliminary clinical study on overweight/obese subjects

All in all, glutathione as a possible therapeutic adjunct in oral disease management displays significant clinical prospects in decreasing oxidative damage and improving oral health

Active site-directed double mutants of dihydrofolate reductase

Diabetes and Metabolic Syndrome & Obesity